Head and Neck Diseases by Alexandros G.Sfakianakis: Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial

Δευτέρα 14 Αυγούστου 2017

Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial

Thyroid , Vol. 0, No. 0.

http://ift.tt/2uCYpbI

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου